 Sujatha Jagannathan
Concepts (151)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Muscular Dystrophy, Facioscapulohumeral | 10 | 2023 | 15 | 4.980 |
Why?
| | Nonsense Mediated mRNA Decay | 4 | 2023 | 8 | 2.500 |
Why?
| | Homeodomain Proteins | 9 | 2023 | 465 | 1.970 |
Why?
| | Codon, Nonsense | 3 | 2023 | 37 | 1.390 |
Why?
| | Endoplasmic Reticulum | 5 | 2021 | 234 | 1.350 |
Why?
| | Ribosomes | 4 | 2023 | 148 | 1.340 |
Why?
| | RNA, Messenger | 11 | 2023 | 2550 | 1.290 |
Why?
| | RNA | 4 | 2023 | 806 | 1.180 |
Why?
| | Protein Biosynthesis | 3 | 2023 | 386 | 1.050 |
Why?
| | Proteomics | 3 | 2023 | 815 | 0.920 |
Why?
| | Gene Expression Regulation | 7 | 2023 | 2322 | 0.840 |
Why?
| | Transcriptome | 3 | 2016 | 721 | 0.700 |
Why?
| | Polyribosomes | 3 | 2014 | 22 | 0.680 |
Why?
| | Proteins | 3 | 2023 | 906 | 0.630 |
Why?
| | Drosophila melanogaster | 1 | 2019 | 188 | 0.580 |
Why?
| | Myotonic Dystrophy | 1 | 2017 | 6 | 0.570 |
Why?
| | Myoblasts | 2 | 2017 | 76 | 0.550 |
Why?
| | RNA-Binding Proteins | 4 | 2023 | 344 | 0.530 |
Why?
| | Transcription, Genetic | 3 | 2021 | 1310 | 0.470 |
Why?
| | MicroRNAs | 1 | 2019 | 600 | 0.430 |
Why?
| | Protein Transport | 1 | 2014 | 391 | 0.410 |
Why?
| | Genes, Homeobox | 2 | 2023 | 51 | 0.400 |
Why?
| | Genomics | 1 | 2016 | 631 | 0.390 |
Why?
| | Cell Fractionation | 1 | 2011 | 51 | 0.360 |
Why?
| | Codon, Terminator | 2 | 2023 | 21 | 0.350 |
Why?
| | Models, Biological | 1 | 2016 | 1611 | 0.330 |
Why?
| | Muscle, Skeletal | 5 | 2023 | 1468 | 0.330 |
Why?
| | Mutation | 2 | 2017 | 3338 | 0.280 |
Why?
| | Cytosol | 3 | 2021 | 201 | 0.240 |
Why?
| | RNA Stability | 2 | 2023 | 90 | 0.230 |
Why?
| | Humans | 19 | 2023 | 114077 | 0.230 |
Why?
| | Transcription Factors | 2 | 2023 | 1526 | 0.220 |
Why?
| | Serine-Arginine Splicing Factors | 1 | 2023 | 18 | 0.210 |
Why?
| | Open Reading Frames | 1 | 2023 | 117 | 0.200 |
Why?
| | Mammals | 1 | 2023 | 241 | 0.190 |
Why?
| | Unfolded Protein Response | 1 | 2021 | 44 | 0.190 |
Why?
| | Muscular Atrophy | 1 | 2022 | 78 | 0.190 |
Why?
| | Cytoplasmic Granules | 1 | 2021 | 81 | 0.180 |
Why?
| | Blotting, Western | 2 | 2014 | 1143 | 0.170 |
Why?
| | Stress, Physiological | 2 | 2021 | 379 | 0.160 |
Why?
| | Base Sequence | 1 | 2023 | 2114 | 0.160 |
Why?
| | Muscle Fibers, Skeletal | 2 | 2018 | 185 | 0.150 |
Why?
| | Cells, Cultured | 2 | 2016 | 3862 | 0.150 |
Why?
| | Cell Line | 3 | 2019 | 2629 | 0.150 |
Why?
| | HeLa Cells | 2 | 2021 | 563 | 0.140 |
Why?
| | Trans-Activators | 2 | 2017 | 366 | 0.140 |
Why?
| | Myoblasts, Skeletal | 1 | 2017 | 11 | 0.140 |
Why?
| | Subcellular Fractions | 2 | 2014 | 77 | 0.140 |
Why?
| | Placenta | 1 | 2023 | 628 | 0.140 |
Why?
| | RNA, Double-Stranded | 1 | 2017 | 44 | 0.140 |
Why?
| | Muscle Development | 1 | 2017 | 99 | 0.140 |
Why?
| | Loss of Function Mutation | 1 | 2016 | 36 | 0.130 |
Why?
| | Rhabdomyosarcoma | 1 | 2017 | 55 | 0.130 |
Why?
| | Cell Plasticity | 1 | 2016 | 23 | 0.130 |
Why?
| | Ubiquitin-Protein Ligases | 1 | 2017 | 139 | 0.130 |
Why?
| | HEK293 Cells | 3 | 2017 | 589 | 0.130 |
Why?
| | Proto-Oncogene Proteins c-myc | 1 | 2017 | 116 | 0.130 |
Why?
| | Genetic Fitness | 1 | 2016 | 53 | 0.130 |
Why?
| | RNA Splicing | 1 | 2017 | 244 | 0.130 |
Why?
| | Alternative Splicing | 1 | 2017 | 186 | 0.130 |
Why?
| | Biomarkers | 2 | 2023 | 3397 | 0.130 |
Why?
| | Animals | 4 | 2023 | 31570 | 0.120 |
Why?
| | Signal Recognition Particle | 1 | 2014 | 8 | 0.120 |
Why?
| | Retroelements | 1 | 2015 | 38 | 0.120 |
Why?
| | Feedback, Physiological | 1 | 2015 | 68 | 0.120 |
Why?
| | SEC Translocation Channels | 1 | 2014 | 10 | 0.120 |
Why?
| | Protein Sorting Signals | 1 | 2014 | 16 | 0.120 |
Why?
| | Genome, Human | 1 | 2016 | 347 | 0.120 |
Why?
| | Genetic Variation | 1 | 2019 | 868 | 0.120 |
Why?
| | Sequence Analysis, RNA | 1 | 2016 | 388 | 0.110 |
Why?
| | Immunoenzyme Techniques | 1 | 2014 | 192 | 0.110 |
Why?
| | Epigenesis, Genetic | 1 | 2018 | 517 | 0.110 |
Why?
| | Fluorescent Antibody Technique | 1 | 2014 | 396 | 0.110 |
Why?
| | Real-Time Polymerase Chain Reaction | 1 | 2014 | 314 | 0.110 |
Why?
| | In Situ Hybridization, Fluorescence | 1 | 2014 | 308 | 0.110 |
Why?
| | Peptide Chain Termination, Translational | 1 | 2012 | 5 | 0.110 |
Why?
| | Oligonucleotide Array Sequence Analysis | 1 | 2014 | 742 | 0.100 |
Why?
| | Reverse Transcriptase Polymerase Chain Reaction | 1 | 2014 | 924 | 0.100 |
Why?
| | Antigen Presentation | 1 | 2012 | 188 | 0.100 |
Why?
| | Histocompatibility Antigens Class I | 1 | 2012 | 170 | 0.090 |
Why?
| | Cell Compartmentation | 1 | 2011 | 51 | 0.090 |
Why?
| | Pregnancy | 1 | 2023 | 5503 | 0.090 |
Why?
| | Denaturing Gradient Gel Electrophoresis | 1 | 2011 | 2 | 0.090 |
Why?
| | Chemical Fractionation | 1 | 2011 | 28 | 0.090 |
Why?
| | Centrifugation | 1 | 2011 | 31 | 0.090 |
Why?
| | RNA Transport | 1 | 2011 | 23 | 0.090 |
Why?
| | Detergents | 1 | 2011 | 41 | 0.090 |
Why?
| | Blotting, Northern | 1 | 2011 | 193 | 0.090 |
Why?
| | Indicators and Reagents | 1 | 2011 | 99 | 0.090 |
Why?
| | Cytoplasm | 1 | 2011 | 255 | 0.090 |
Why?
| | Electrophoresis, Polyacrylamide Gel | 1 | 2011 | 315 | 0.090 |
Why?
| | Cell Differentiation | 1 | 2017 | 1696 | 0.090 |
Why?
| | Gene Expression Profiling | 1 | 2016 | 1519 | 0.090 |
Why?
| | Microscopy, Fluorescence | 1 | 2011 | 393 | 0.080 |
Why?
| | Membrane Proteins | 1 | 2014 | 1016 | 0.080 |
Why?
| | Apoptosis | 1 | 2017 | 2349 | 0.070 |
Why?
| | RNA Helicases | 2 | 2017 | 20 | 0.070 |
Why?
| | Proteolysis | 2 | 2017 | 142 | 0.060 |
Why?
| | Adolescent | 1 | 2022 | 17811 | 0.060 |
Why?
| | Proteasome Endopeptidase Complex | 2 | 2015 | 133 | 0.050 |
Why?
| | Dithiothreitol | 1 | 2021 | 17 | 0.050 |
Why?
| | Organelle Biogenesis | 1 | 2021 | 14 | 0.050 |
Why?
| | Dactinomycin | 1 | 2021 | 25 | 0.050 |
Why?
| | Phenanthrenes | 1 | 2021 | 10 | 0.050 |
Why?
| | Diterpenes | 1 | 2021 | 31 | 0.050 |
Why?
| | beta 2-Microglobulin | 1 | 2021 | 44 | 0.050 |
Why?
| | Epoxy Compounds | 1 | 2021 | 31 | 0.050 |
Why?
| | Peptide Chain Initiation, Translational | 1 | 2021 | 38 | 0.050 |
Why?
| | Single Molecule Imaging | 1 | 2021 | 30 | 0.050 |
Why?
| | Heat-Shock Proteins | 1 | 2021 | 112 | 0.040 |
Why?
| | Adult | 1 | 2022 | 30394 | 0.040 |
Why?
| | Proteome | 1 | 2023 | 337 | 0.040 |
Why?
| | Membrane Glycoproteins | 1 | 2021 | 429 | 0.040 |
Why?
| | Female | 2 | 2023 | 59347 | 0.040 |
Why?
| | Chromatin Assembly Factor-1 | 1 | 2018 | 9 | 0.040 |
Why?
| | Mi-2 Nucleosome Remodeling and Deacetylase Complex | 1 | 2018 | 24 | 0.040 |
Why?
| | Clustered Regularly Interspaced Short Palindromic Repeats | 1 | 2018 | 25 | 0.040 |
Why?
| | MyoD Protein | 1 | 2017 | 28 | 0.040 |
Why?
| | Eukaryotic Initiation Factor-4A | 1 | 2017 | 2 | 0.040 |
Why?
| | Gene Silencing | 1 | 2018 | 171 | 0.040 |
Why?
| | Ubiquitination | 1 | 2017 | 86 | 0.030 |
Why?
| | DEAD-box RNA Helicases | 1 | 2017 | 56 | 0.030 |
Why?
| | Nucleosomes | 1 | 2018 | 122 | 0.030 |
Why?
| | Gene Expression | 1 | 2021 | 1417 | 0.030 |
Why?
| | Protein Domains | 1 | 2017 | 207 | 0.030 |
Why?
| | Exons | 1 | 2017 | 301 | 0.030 |
Why?
| | Caspases | 1 | 2017 | 243 | 0.030 |
Why?
| | RNA Interference | 1 | 2017 | 431 | 0.030 |
Why?
| | Cell Death | 1 | 2017 | 322 | 0.030 |
Why?
| | Transfection | 1 | 2017 | 863 | 0.030 |
Why?
| | Down-Regulation | 1 | 2017 | 594 | 0.030 |
Why?
| | RNA, Small Interfering | 1 | 2017 | 534 | 0.030 |
Why?
| | Chromatin | 1 | 2018 | 424 | 0.030 |
Why?
| | Protein Stability | 1 | 2015 | 156 | 0.030 |
Why?
| | Substrate Specificity | 1 | 2015 | 350 | 0.030 |
Why?
| | Cell Survival | 1 | 2017 | 1014 | 0.030 |
Why?
| | Tumor Suppressor Protein p53 | 1 | 2017 | 445 | 0.030 |
Why?
| | Puromycin | 1 | 2012 | 11 | 0.030 |
Why?
| | Gene Expression Regulation, Developmental | 1 | 2018 | 801 | 0.030 |
Why?
| | Monitoring, Immunologic | 1 | 2012 | 23 | 0.030 |
Why?
| | Myelolipoma | 1 | 2011 | 1 | 0.020 |
Why?
| | Membranes | 1 | 2011 | 18 | 0.020 |
Why?
| | Immunity, Innate | 1 | 2017 | 720 | 0.020 |
Why?
| | Plasmacytoma | 1 | 2011 | 9 | 0.020 |
Why?
| | Metabolic Networks and Pathways | 1 | 2011 | 167 | 0.020 |
Why?
| | Peptides | 1 | 2012 | 847 | 0.020 |
Why?
| | Time Factors | 1 | 2017 | 6077 | 0.020 |
Why?
| | Cell Line, Tumor | 1 | 2011 | 2699 | 0.010 |
Why?
| | Signal Transduction | 1 | 2017 | 4501 | 0.010 |
Why?
| | Mice | 1 | 2011 | 14847 | 0.010 |
Why?
| | Male | 1 | 2017 | 55418 | 0.010 |
Why?
|
|
Jagannathan's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors People whose addresses are nearby this person. _
|